HOME › DRUGS › TEPOTINIB
ACTIVE SUBSTANCE / INN

TEPOTINIB

Brand name(s): Tepmetko
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Tepotinib
REGULATORS
EMA
SPONSORS / MAH
Merck Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TepmetkoMerck Europe B.V.Authorised16/02/2022Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON TEPOTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →